マルチプレックスアッセイ市場

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2021年12月

マルチプレックスアッセイ市場: 製品(消耗品、機器、ソフトウェア、サービス)、タイプ(核酸、タンパク質、細胞)、技術(フローサイトメトリー、発光、用途(R&D、診断)、エンドユーザー(医薬&バイオテクノロジー、病院)- 2026年までの世界予測

Multiplex Assays Market by product (Consumables, Instruments, Software & Services), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence, Application (R&D, Diagnosis), End User (Pharma & Biotech, Hospital) – Global Forecast to 2026

ページ数257
図表数284
種別英文調査報告書
価格

レポート目次    見積ご依頼・お問合せ    ご購入案内

無料サンプル

The global Multiplex Assays Market is projected to reach USD 4.3 billion by 2026 from USD 3.0 billion in 2021, at a CAGR of 7.6% during the forecast period. Market growth is mainly driven by factors such as the increasing adoption of companion diagnostics, the increasing incidence of chronic and infectious diseases, the growing awareness of the disease diagnosis, and the need for effective analytical platforms in research and clinical diagnostics to reduce the operational costs and the time taken for diagnosis. However, the high cost of multiplex assay equipment, stringent regulations and standards, and issues in the standardization of multiplex assays design are the major factors restraining the growth of this market.

“Product and Service accounted for the largest share of the Multiplex Assays Market and is expected to grow at the highest CAGR in the forecast period.”

Based on product & service, the multiplex assays market is segmented into instruments, consumables, and software & services. In 2020, the consumables segment is expected to account for the largest share of the market; it is also the fastest-growing segment of the multiplex assays market. This can be attributed to the recurring purchase of assays and reagents for increasing research applications.

“Protein-based multiplex assays segment is expected to account for the largest share of the global multiplex assays market and is expected to grow at the highest CAGR in the forecast period.”
Based on type, the global multiplex assays market is divided into protein-based multiplex assays, nucleic acid-based multiplex assays, and cell-based multiplex assays. In 2020, the protein-based multiplex assays segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the increasing focus on proteomics studies for biomarker research and clinical diagnostics.

“Flow cytometry segment is expected to account for the largest share of the global multiplex assays market and is expected to grow at the highest CAGR in the forecast period.”
On the basis of technology, the global multiplex assays market is divided into flow cytometry, multiplex RT PCR, luminescence, fluorescence detection, and other technologies. In 2020, the flow cytometry segment is expected to account for the largest share of the global multiplex assays market. The large share can be attributed to the wide applications of flow cytometry in the detection and measurement of protein expression, RNA, and cell health status (cell viability & toxicity) alongside the characterization and identification of various cell types.

“Research & development companies account for the largest share of the Multiplex Assays Market in 2020 and is expected to grow at the fastest CAGR in the forecast period.”
On the basis of application, the global multiplex assays market is divided into research & development and clinical diagnostics. In 2020, the research & development segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the wide applications of multiplex assay technologies in research & development functions.

“Pharmaceutical & biotechnology companies account for the largest share of the Multiplex Assays Market in 2020 and is expected to grow at the fastest CAGR in the forecast period.”
Based on end user, the multiplex assays market is segmented into pharmaceutical & biotechnology companies, hospitals & research institutes, reference laboratories and other end users. In 2020, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the increasing adoption of multiplex assays in drug discovery and development by pharmaceuticals and the growing focus of biotechnology companies on developing biosimilars and monoclonal antibodies.
“North America will dominate the market during the forecast period.”
Geographically, the Multiplex Assays Market is segmented into four major regions, namely, North America (US and Canada), Europe, Asia Pacific, and Rest of the world. North America was the largest regional market for Multiplex Assays Market in 2020. North America is expected to account for the largest share of the multiplex assays market in 2020, followed by Europe. The dominant share of the North American market is primarily attributed to its established pharmaceutical industry, presence of leading pharmaceutical and biotechnology companies, and high R&D investment.

The primary interviews conducted for this report can be categorized as follows:

•By Company Type – Tier 1: 42%, Tier 2: 37%, and Tier 3: 21%
•By Designation – C-level: 34%, D-level: 42%, and Others: 23%
•By Region – North America: 32%, Europe: 30%, Asia Pacific: 24%, and Rest of the World: 14%
List of Companies Profiled in the Report
•Luminex Corporation (US)
•Thermo Fisher Scientific Inc. (US)
•Illumina, Inc (US)
•Bio-Rad Laboratories, Inc. (US)
•Qiagen N.V. (Netherlands)
•Abcam plc (UK)
•Becton, Dickinson and Company (US)
•Merck KGaA (Germany)
•Agilent Technologies, Inc. (US)
•Meso Scale Diagnostics (US)
•Randox Laboratories (UK)
•Quanterix (US)
•Bio-Techne Corporation (US)
•Olink (Sweden)
•DiaSorin S.p.A. (Italy)
•Seegene (South Korea)
•Promega Corporation (US)
•Siemens Healthineers (Germany)
•PerkinElmer, Inc. (US)
•Shimadzu Biotech (Japan)
•Antigenix America, Inc. (US)
•Enzo Life Sciences, Inc. (US)
•Boster Biological Technology (US)
•AYOXXA Biosystems GmbH (Germany)
•Cayman Chemical Company (US).

Research Coverage:
This report provides a detailed picture of the global multiplex assays market. It aims at estimating the size and future growth potential of the market across different segments, such as type, end user and region. The report also analyzes factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total multiplex assays market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
•Market Penetration: Comprehensive information on multiplex assays offered by the top 15 players in the multiplex assays market. The report analyses the multiplex assays market by product & service, type, technology, application, end user, and region

•Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for various multiplex assays across key geographic regions.

•Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the multiplex assays market.

•Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the multiplex assays market.


目次

1INTRODUCTION32
1.1OBJECTIVES OF THE STUDY32
1.2MARKET DEFINITION32
TABLE 1INCLUSIONS & EXCLUSIONS OF THE STUDY32
1.3MARKET SCOPE33
1.3.1MARKETS COVERED33
1.3.2YEARS CONSIDERED FOR THE STUDY34
1.4CURRENCY34
TABLE 2EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD34
1.5STAKEHOLDERS35
1.6LIMITATIONS35
2RESEARCH METHODOLOGY36
2.1RESEARCH DATA36
FIGURE 1MULTIPLEX ASSAYS MARKET: RESEARCH DESIGN36
2.1.1SECONDARY DATA37
2.1.1.1Key data from secondary sources38
2.2PRIMARY DATA38
2.2.1KEY DATA FROM PRIMARY SOURCES39
2.2.1.1Key data from primary sources40
2.2.1.2Key industry insights41
FIGURE 2BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION42
2.3MARKET SIZE ESTIMATION42
FIGURE 3MULTIPLEX ASSAYS MARKET – REVENUE SHARE ANALYSIS
ILLUSTRATION: ILLUMINA, INC.43
FIGURE 4MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF MULTIPLEX ASSAY PRODUCTS44
FIGURE 5CAGR PROJECTIONS45
FIGURE 6TOP-DOWN APPROACH46
2.4MARKET BREAKDOWN AND DATA TRIANGULATION47
2.4.1SECONDARY DATA47
2.4.2PRIMARY DATA47
2.5DATA TRIANGULATION METHODOLOGY48
FIGURE 7DATA TRIANGULATION48
2.6MARKET SHARE ANALYSIS49
2.7ASSUMPTIONS FOR THE STUDY49
2.8INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY50
2.8.1COVID-19-SPECIFIC ASSUMPTIONS51
2.9LIMITATIONS51
2.10RISK ASSESSMENT52
TABLE 3RISK ASSESSMENT52
2.11COVID-19 HEALTH ASSESSMENT52
2.12COVID-19 ECONOMIC ASSESSMENT52
2.13ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO52
FIGURE 8CRITERIA IMPACTING THE GLOBAL ECONOMY53
FIGURE 9RECOVERY SCENARIO OF THE GLOBAL ECONOMY54
2.14ASSESSMENT OF THE IMPACT OF COVID-19 ON THE MULTIPLEX ASSAYS MARKET55
3EXECUTIVE SUMMARY56
FIGURE 10MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD BILLION)56
FIGURE 11MULTIPLEX ASSAYS MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION )57
FIGURE 12MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD BILLION)57
FIGURE 13MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2021 VS. 2026 (USD BILLION )58
FIGURE 14MULTIPLEX ASSAYS MARKET, BY END USER, 2021 VS. 2026 (USD BILLION)58
FIGURE 15GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET
(2021–2026)59
4PREMIUM INSIGHTS60
4.1MULTIPLEX ASSAYS MARKET OVERVIEW60
FIGURE 16INCREASING ADOPTION OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS TO DRIVE THE MARKET GROWTH60
4.2NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION AND COUNTRY (2020)61
FIGURE 17R&D TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN MULTIPLEX ASSAYS MARKET IN 202061
4.3MULTIPLEX ASSAYS MARKET, BY REGION (2021 VS. 2026)61
FIGURE 18NORTH AMERICA TO DOMINATE THE MULTIPLEX ASSAYS MARKET IN 202661
4.4GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET62
FIGURE 19APAC TO BE THE FASTEST-GROWING MARKET FROM 2021 TO 202662
5MARKET OVERVIEW63
5.1INTRODUCTION63
5.2MARKET DYNAMICS63
FIGURE 20GLOBAL MULTIPLEX ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES63
5.2.1DRIVERS64
5.2.1.1Increasing use of multiplex assays in companion diagnostics64
5.2.1.2Increasing advantages over singleplex and traditional assays64
5.2.1.3Increasing incidence of chronic and infectious diseases and growing awareness about early disease diagnosis65

FIGURE 21INCIDENCE OF DIABETES, BY REGION, 2019, 2030, AND 204565
TABLE 4GLOBAL INCIDENCE OF INFECTIOUS DISEASES66
TABLE 5APPROVED AND LAUNCHED MULTIPLEX ASSAYS FOR THE DIAGNOSIS OF SARS-COV-266
5.2.2RESTRAINTS68
5.2.2.1Increasing costs of equipment68
5.2.2.2Growing number of stringent regulations and standards68
5.2.3OPPORTUNITIES68
5.2.3.1Increasing validation of biomarkers in molecular and protein diagnostics68
5.2.3.2Rising need for high-throughput and automated systems68
5.2.4CHALLENGES69
5.2.4.1Increasing dearth of skilled professionals69
6MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE70
6.1INTRODUCTION71
TABLE 6MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE,
2016–2020 (USD MILLION)71
TABLE 7MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE,
2021–2026 (USD MILLION)71
6.2CONSUMABLES71
TABLE 8MULTIPLEX ASSAY CONSUMABLES MARKET, BY REGION,
2016–2020 (USD MILLION)72
TABLE 9MULTIPLEX ASSAY CONSUMABLES MARKET, BY REGION,
2021–2026 (USD MILLION)72
TABLE 10NORTH AMERICA: MULTIPLEX ASSAY CONSUMABLES MARKET, BY COUNTRY, 2016–2020 (USD MILLION)73
TABLE 11NORTH AMERICA: MULTIPLEX ASSAY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)73
6.3INSTRUMENTS73
TABLE 12MULTIPLEX ASSAY INSTRUMENTS MARKET, BY REGION,
2016–2020 (USD MILLION)74
TABLE 13MULTIPLEX ASSAY INSTRUMENT MARKET, BY REGION,
2021–2026 (USD MILLION)74
TABLE 14NORTH AMERICA: MULTIPLEX ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2016–2020 (USD MILLION)74
TABLE 15NORTH AMERICA: MULTIPLEX ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)75
6.4SOFTWARE & SERVICES75
TABLE 16MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET, BY REGION,
2016–2020 (USD MILLION)75
TABLE 17MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET, BY REGION,
2021–2026 (USD MILLION)76
TABLE 18NORTH AMERICA: MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET,
BY COUNTRY, 2016–2020 (USD MILLION)76
TABLE 19NORTH AMERICA: MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET,
BY COUNTRY, 2021–2026 (USD MILLION)76
7MULTIPLEX ASSAYS MARKET, BY TYPE77
7.1INTRODUCTION78
TABLE 20MULTIPLEX ASSAYS MARKET, BY TYPE, 2016–2020 (USD MILLION)78
TABLE 21MULTIPLEX ASSAYS MARKET, BY TYPE, 2021–2026 (USD MILLION)78
7.2PROTEIN MULTIPLEX ASSAYS78
TABLE 22PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2016–2020 (USD MILLION)79
TABLE 23PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2021–2026 (USD MILLION)79
TABLE 24PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION,
2016–2020 (USD MILLION)79
TABLE 25PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION,
2021–2026(USD MILLION)80
TABLE 26NORTH AMERICA: PROTEIN MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016–2020 (USD MILLION)80
TABLE 27NORTH AMERICA: PROTEIN MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)80
7.2.1PLANAR PROTEIN ASSAYS81
TABLE 28PLANAR PROTEIN ASSAYS MARKET, BY REGION, 2016–2020 (USD MILLION)81
TABLE 29PLANAR PROTEIN ASSAYS MARKET, BY REGION, 2021–2026(USD MILLION)81
TABLE 30NORTH AMERICA: PLANAR PROTEIN ASSAYS MARKET, BY COUNTRY,
2016–2020 (USD MILLION)82
TABLE 31NORTH AMERICA: PLANAR PROTEIN ASSAYS MARKET, BY COUNTRY,
2021–2026 (USD MILLION)82
7.2.2BEAD-BASED PROTEIN ASSAYS82
TABLE 32BEAD-BASED PROTEIN ASSAYS MARKET, BY REGION,
2016–2020 (USD MILLION)83
TABLE 33BEAD-BASED PROTEIN ASSAYS MARKET, BY REGION,
2021–2026 (USD MILLION)83
TABLE 34NORTH AMERICA: BEAD-BASED PROTEIN ASSAYS MARKET, BY COUNTRY, 2016–2020 (USD MILLION)83
TABLE 35NORTH AMERICA: BEAD-BASED PROTEIN ASSAYS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)84
7.2.3OTHER PROTEIN ASSAYS84
TABLE 36OTHER PROTEIN ASSAYS MARKET, BY REGION, 2016–2020 (USD MILLION)84
TABLE 37OTHER PROTEIN ASSAYS MARKET, BY REGION, 2021–2026(USD MILLION)85
TABLE 38NORTH AMERICA: OTHER PROTEIN ASSAYS MARKET, BY COUNTRY,
2016–2020 (USD MILLION)85
TABLE 39NORTH AMERICA: OTHER PROTEIN ASSAYS MARKET, BY COUNTRY,
2021–2026 (USD MILLION)85
7.3NUCLEIC ACID MULTIPLEX ASSAYS86
TABLE 40SOME OF THE FDA AUTHORIZED MULTIPLEX ASSAYS AND INSTRUMENTS AUTHORIZED FOR THE SIMULTANEOUS DETECTION OF INFLUENZA VIRUSES AND SARS-COV-286
TABLE 41NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE,
2016–2020 (USD MILLION)88
TABLE 42NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE,
2021–2026 (USD MILLION)89
TABLE 43NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION,
2016–2020 (USD MILLION)89
TABLE 44NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION,
2021–2026 (USD MILLION)89
TABLE 45NORTH AMERICA: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016–2020 (USD MILLION)90
TABLE 46NORTH AMERICA: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)90
7.3.1PLANAR NUCLEIC ACID ASSAYS90
TABLE 47PLANAR NUCLEIC ACID ASSAYS MARKET, BY REGION,
2016–2020 (USD MILLION)91
TABLE 48PLANAR NUCLEIC ACID ASSAYS MARKET, BY REGION,
2021–2026 (USD MILLION)91
TABLE 49NORTH AMERICA: PLANAR NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016–2020 (USD MILLION)91
TABLE 50NORTH AMERICA: PLANAR NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)92
7.3.2BEAD-BASED NUCLEIC ACID ASSAYS92
TABLE 51BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY REGION,
2016–2020 (USD MILLION)92
TABLE 52BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY REGION,
2021–2026 (USD MILLION)93
TABLE 53NORTH AMERICA: BEAD-BASED NUCLEIC ACID ASSAYS MARKET,
BY COUNTRY, 2016–2020 (USD MILLION)93
TABLE 54NORTH AMERICA: BEAD-BASED NUCLEIC ACID ASSAYS MARKET,
BY COUNTRY, 2021–2026 (USD MILLION)93
7.3.3OTHER NUCLEIC ACID ASSAYS94
TABLE 55OTHER NUCLEIC ACID ASSAYS MARKET, BY REGION,
2016–2020 (USD MILLION)94
TABLE 56OTHER NUCLEIC ACID ASSAYS MARKET, BY REGION,
2021–2026 (USD MILLION)94
TABLE 57NORTH AMERICA: OTHER NUCLEIC ACID ASSAYS MARKET,
BY COUNTRY, 2016–2020 (USD MILLION)94
TABLE 58NORTH AMERICA: OTHER NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)95
7.4CELL-BASED MULTIPLEX ASSAYS95
TABLE 59CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION,
2016–2020 (USD MILLION)95
TABLE 60CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION,
2021–2026 (USD MILLION)96
TABLE 61NORTH AMERICA: CELL-BASED MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016–2020 (USD MILLION)96
TABLE 62NORTH AMERICA: CELL-BASED MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)96

8MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY97
8.1INTRODUCTION98
TABLE 63MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016–2020 (USD MILLION)98
TABLE 64MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021–2026 (USD MILLION)98
8.2FLOW CYTOMETRY99
TABLE 65MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION,
2016–2020 (USD MILLION)99
TABLE 66MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION,
2021–2026 (USD MILLION)100
TABLE 67NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2016–2020 (USD MILLION)100
TABLE 68NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2021–2026 (USD MILLION)100
8.3FLUORESCENCE DETECTION101
TABLE 69MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY REGION, 2016–2020 (USD MILLION)101
TABLE 70MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY REGION, 2021–2026 (USD MILLION)101
TABLE 71NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY COUNTRY, 2016–2020 (USD MILLION)102
TABLE 72NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY COUNTRY, 2021–2026 (USD MILLION)102
8.4LUMINESCENCE102
TABLE 73MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY REGION,
2016–2020 (USD MILLION)103
TABLE 74MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY REGION,
2021–2026 (USD MILLION)103
TABLE 75NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE,
BY COUNTRY, 2016–2020 (USD MILLION)103
TABLE 76NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE,
BY COUNTRY, 2021–2026 (USD MILLION)104
8.5MULTIPLEX REAL-TIME PCR104
TABLE 77MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY REGION,
2016–2020 (USD MILLION)105
TABLE 78MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY REGION,
2021–2026 (USD MILLION)105
TABLE 79NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR,
BY COUNTRY, 2016–2020 (USD MILLION)105
TABLE 80NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR,
BY COUNTRY, 2021–2026 (USD MILLION)106
8.6OTHER TECHNOLOGIES106
TABLE 81MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016–2020 (USD MILLION)107
TABLE 82MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2026 (USD MILLION)107
TABLE 83NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2020 (USD MILLION)107
TABLE 84NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2026 (USD MILLION)108
9MULTIPLEX ASSAYS MARKET, BY APPLICATION109
9.1INTRODUCTION110
TABLE 85MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016–2020 (USD MILLION)110
TABLE 86MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021–2026 (USD MILLION)110
9.2RESEARCH & DEVELOPMENT111
TABLE 87MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2016–2020 (USD MILLION)111
TABLE 88MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2021–2026 (USD MILLION)111
TABLE 89MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2016–2020 (USD MILLION)111
TABLE 90MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2021–2026 (USD MILLION)112
TABLE 91NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2016–2020 (USD MILLION)112
TABLE 92NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)112
9.2.1DRUG DISCOVERY & DEVELOPMENT113
TABLE 93MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY REGION, 2016–2020 (USD MILLION)113
TABLE 94MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY REGION, 2021–2026 (USD MILLION)113
TABLE 95NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2016–2020 (USD MILLION)114
TABLE 96NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)114
9.2.2BIOMARKER DISCOVERY & VALIDATION114
TABLE 97MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION,
BY REGION, 2016–2020 (USD MILLION)115
TABLE 98MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION,
BY REGION, 2021–2026 (USD MILLION)115
TABLE 99NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY COUNTRY, 2016–2020 (USD MILLION)115
TABLE 100NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY COUNTRY, 2021–2026 (USD MILLION)116
9.3CLINICAL DIAGNOSTICS116
TABLE 101MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2016–2020 (USD MILLION)116
TABLE 102MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,
2021–2026 (USD MILLION)117
TABLE 103MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2016–2020 (USD MILLION)117
TABLE 104MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2021–2026 (USD MILLION)118
TABLE 105NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2016–2020 (USD MILLION)118
TABLE 106NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2026 (USD MILLION)118
9.3.1INFECTIOUS DISEASES119
TABLE 107MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS,
BY REGION, 2016–2020 (USD MILLION)120
TABLE 108MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS,
BY REGION, 2021–2026 (USD MILLION)120
TABLE 109NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2016–2020 (USD MILLION)120
TABLE 110NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2026 (USD MILLION)121
9.3.2CANCER121
TABLE 111INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS.
2030 VS. 2040 (MILLION)122
TABLE 112MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2016–2020 (USD MILLION)122
TABLE 113MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2021–2026 (USD MILLION)122
TABLE 114NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2016–2020 (USD MILLION)123
TABLE 115NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2021–2026 (USD MILLION)123
9.3.3CARDIOVASCULAR DISEASES123
TABLE 116MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY REGION, 2016–2020 (USD MILLION)124
TABLE 117MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY REGION, 2021–2026 (USD MILLION)124
TABLE 118NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY COUNTRY, 2016–2020 (USD MILLION)124
TABLE 119NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2026 (USD MILLION)125
9.3.4AUTOIMMUNE DISEASES125
TABLE 120PREVALENCE OF SOME AUTOIMMUNE DISEASES125
TABLE 121MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS,
BY REGION, 2016–2020 (USD MILLION)126
TABLE 122MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS,
BY REGION, 2021–2026 (USD MILLION)126
TABLE 123NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2016–2020 (USD MILLION)127
TABLE 124NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2026 (USD MILLION)127
9.3.5NERVOUS SYSTEM DISORDERS127
TABLE 125MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY REGION, 2016–2020 (USD MILLION)128
TABLE 126MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY REGION, 2021–2026 (USD MILLION)128
TABLE 127NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY COUNTRY, 2016–2020 (USD MILLION)128
TABLE 128NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY COUNTRY, 2021–2026 (USD MILLION)129
9.3.6METABOLISM & ENDOCRINOLOGY DISORDERS129
TABLE 129MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY REGION, 2016–2020 (USD MILLION)129
TABLE 130MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY REGION, 2021–2026 (USD MILLION)130
TABLE 131NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY COUNTRY,
2016–2020 (USD MILLION)130
TABLE 132NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY COUNTRY,
2021–2026 (USD MILLION)130
9.3.7OTHER DISEASES131
TABLE 133MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES, BY REGION,
2016–2020 (USD MILLION)131
TABLE 134MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES, BY REGION,
2021–2026 (USD MILLION)131
TABLE 135NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES,
BY COUNTRY, 2016–2020 (USD MILLION)132
TABLE 136NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES,
BY COUNTRY, 2021–2026 (USD MILLION)132
10MULTIPLEX ASSAYS MARKET, BY END USER133
10.1INTRODUCTION134
TABLE 137MULTIPLEX ASSAYS MARKET, BY END USER, 2016–2020 (USD MILLION)134
TABLE 138MULTIPLEX ASSAYS MARKET, BY END USER, 2021–2026(USD MILLION)134
10.2PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES135
TABLE 139MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2020 (USD MILLION)135
TABLE 140MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2026 (USD MILLION)135
TABLE 141NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2020 (USD MILLION)136
TABLE 142NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)136
10.3HOSPITALS & RESEARCH INSTITUTES136
TABLE 143MULTIPLEX ASSAYS MARKET FOR HOSPITALS & RESEARCH INSTITUTES,
BY REGION, 2016–2020 (USD MILLION)137
TABLE 144MULTIPLEX ASSAYS MARKET FOR HOSPITALS & RESEARCH INSTITUTES,
BY REGION, 2021–2026 (USD MILLION)137
TABLE 145NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR HOSPITAL & RESEARCH INSTITUTES, BY COUNTRY, 2016–2020 (USD MILLION)138
TABLE 146NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR HOSPITAL & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)138

10.4REFERENCE LABORATORIES138
TABLE 147MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2016–2020 (USD MILLION)139
TABLE 148MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2021–2026 (USD MILLION)139
TABLE 149NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2016–2020 (USD MILLION)139
TABLE 150NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2026 (USD MILLION)140
10.5OTHER END USERS140
TABLE 151MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY REGION,
2016–2020 (USD MILLION)141
TABLE 152MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY REGION,
2021–2026 (USD MILLION)141
TABLE 153NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER END USERS,
BY COUNTRY, 2016–2020 (USD MILLION)141
TABLE 154NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER END USERS,
BY COUNTRY, 2021–2026 (USD MILLION)142
11MULTIPLEX ASSAYS MARKET, BY REGION143
11.1INTRODUCTION144
TABLE 155MULTIPLEX ASSAYS MARKET, BY REGION, 2016–2020 (USD MILLION)144
TABLE 156MULTIPLEX ASSAYS MARKET, BY REGION, 2021–2026 (USD MILLION)144
11.2NORTH AMERICA145
FIGURE 22NORTH AMERICA: MULTIPLEX ASSAYS MARKET SNAPSHOT146
TABLE 157NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY COUNTRY,
2016–2020 (USD MILLION)147
TABLE 158NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY COUNTRY,
2021–2026 (USD MILLION)147
TABLE 159NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016–2020 (USD MILLION)147
TABLE 160NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)148
TABLE 161NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TYPE,
2016–2020 (USD MILLION)148
TABLE 162NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TYPE,
2021–2026 (USD MILLION)148
TABLE 163NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2016–2020 (USD MILLION)149
TABLE 164NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)149
TABLE 165NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2016–2020 (USD MILLION)149
TABLE 166NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)150
TABLE 167NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY END USER,
2016–2020 (USD MILLION)150
TABLE 168NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY END USER,
2021–2026 (USD MILLION)150
11.2.1US151
TABLE 169US: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)151
TABLE 170US: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)152
TABLE 171US: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016–2020 (USD MILLION)152
TABLE 172US: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021–2026 (USD MILLION)152
TABLE 173US: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2016–2020 (USD MILLION)153
TABLE 174US: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)153
TABLE 175US: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2016–2020 (USD MILLION)153
TABLE 176US: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)154
TABLE 177US: MULTIPLEX ASSAYS MARKET, BY END USER, 2016–2020 (USD MILLION)154
TABLE 178US: MULTIPLEX ASSAYS MARKET, BY END USER, 2021–2026 (USD MILLION)154
11.2.2CANADA155
TABLE 179CANADA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)155
TABLE 180CANADA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)155
TABLE 181CANADA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016–2020 (USD MILLION)156
TABLE 182CANADA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021–2026 (USD MILLION)156
TABLE 183CANADA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2016–2020 (USD MILLION)156
TABLE 184CANADA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)157
TABLE 185CANADA: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2016–2020 (USD MILLION)157
TABLE 186CANADA: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)157
TABLE 187CANADA: MULTIPLEX ASSAYS MARKET, BY END USER,
2016–2020 (USD MILLION)158
TABLE 188CANADA: MULTIPLEX ASSAYS MARKET, BY END USER,
2021–2026 (USD MILLION)158
11.3EUROPE158
TABLE 189EUROPE: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)160
TABLE 190EUROPE: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)160
TABLE 191EUROPE: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016–2020 (USD MILLION)160
TABLE 192EUROPE: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021–2026 (USD MILLION)161
TABLE 193EUROPE: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2016–2020 (USD MILLION)161
TABLE 194EUROPE: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)161
TABLE 195EUROPE: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2016–2020 (USD MILLION)162
TABLE 196EUROPE: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)162
TABLE 197EUROPE: MULTIPLEX ASSAYS MARKET, BY END USER,
2016–2020 (USD MILLION)162
TABLE 198EUROPE: MULTIPLEX ASSAYS MARKET, BY END USER,
2021–2026 (USD MILLION)163
11.4ASIA PACIFIC163
FIGURE 23ASIA PACIFIC: MULTIPLEX ASSAYS MARKET SNAPSHOT164
TABLE 199ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)165
TABLE 200ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)165
TABLE 201ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TYPE,
2016–2020 (USD MILLION)165
TABLE 202ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TYPE,
2021–2026 (USD MILLION)166
TABLE 203ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2016–2020 (USD MILLION)166
TABLE 204ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)166
TABLE 205ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2016–2020 (USD MILLION)167
TABLE 206ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)167
TABLE 207ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY END USER,
2016–2020 (USD MILLION)167
TABLE 208ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY END USER,
2021–2026 (USD MILLION)168
11.5REST OF THE WORLD168
TABLE 209ROW: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)169
TABLE 210ROW: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)169
TABLE 211ROW: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016–2020 (USD MILLION)170
TABLE 212ROW: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021–2026 (USD MILLION)170
TABLE 213ROW: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2016–2020 (USD MILLION)170
TABLE 214ROW: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)171
TABLE 215ROW: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2016–2020 (USD MILLION)171
TABLE 216ROW: MULTIPLEX ASSAYS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)171
TABLE 217ROW: MULTIPLEX ASSAYS MARKET, BY END USER,
2016–2020 (USD MILLION)172
TABLE 218ROW: MULTIPLEX ASSAYS MARKET, BY END USER,
2021–2026 (USD MILLION)172
12COMPETITIVE LANDSCAPE173
12.1OVERVIEW173
12.2KEY PLAYER STRATEGIES/RIGHT TO WIN173
12.2.1OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE MULTIPLEX ASSAYS MARKET, 2018 TO 2021173
12.3MARKET RANKING ANALYSIS, 2020176
FIGURE 24MULTIPLEX MARKET SHARE ANALYSIS, 2020176
TABLE 219MULTIPLEX ASSAYS MARKET: DEGREE OF COMPETITION177
12.4COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)178
12.4.1STARS178
12.4.2PERVASIVE PLAYERS178
12.4.3EMERGING LEADERS179
12.4.4PARTICIPANTS179
FIGURE 25MULTIPLEX ASSAYS MARKET (GLOBAL):
COMPANY EVALUATION QUADRANT, 2020179
12.5COMPANY EVALUATION QUADRANT (SMES/STARTUPS)180
12.5.1PROGRESSIVE COMPANIES180
12.5.2STARTING BLOCKS180
12.5.3RESPONSIVE COMPANIES180
12.5.4DYNAMIC COMPANIES180
FIGURE 26MULTIPLEX ASSAYS MARKET: COMPANY EVALUATION QUADRANT
FOR START-UPS/SMES, 2020181
12.6COMPETITIVE SITUATION AND TRENDS182
12.6.1PRODUCT LAUNCHES AND APPROVALS182
TABLE 220PRODUCT LAUNCHES AND APPROVALS, 2018–2021182
12.6.2DEALS183
TABLE 221DEALS, 2018–2021183
12.6.3OTHER DEVELOPMENTS184
TABLE 222OTHER DEVELOPMENTS, 2018–2021184
13COMPANY PROFILES186
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1ILLUMINA, INC.186
TABLE 223ILLUMINA, INC.: BUSINESS OVERVIEW186
FIGURE 27COMPANY SNAPSHOT: ILLUMINA, INC. (2020)187
13.2LUMINEX CORPORATION193
TABLE 224LUMINEX CORPORATION: BUSINESS OVERVIEW193
FIGURE 28LUMINEX CORPORATION: COMPANY SNAPSHOT (2020)193

13.3THERMO FISHER SCIENTIFIC INC.197
TABLE 225THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW197
FIGURE 29COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC. (2020)198
13.4BIO-RAD LABORATORIES, INC.203
TABLE 226BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW203
FIGURE 30COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2020)204
13.5BECTON DICKINSON AND COMPANY209
TABLE 227BECTON, DICKINSON AND COMPANY.: BUSINESS OVERVIEW209
FIGURE 31COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020)210
13.6QIAGEN N.V.214
TABLE 228QIAGEN N.V.: BUSINESS OVERVIEW214
FIGURE 32COMPANY SNAPSHOT: QIAGEN N.V. (2020)215
13.7ABCAM PLC218
TABLE 229ABCAM PLC.: BUSINESS OVERVIEW218
FIGURE 33COMPANY SNAPSHOT: ABCAM PLC (2020)219
13.8MERCK KGAA223
TABLE 230MERCK KGAA.: BUSINESS OVERVIEW223
FIGURE 34COMPANY SNAPSHOT: MERCK KGAA (2020)224
13.9AGILENT TECHNOLOGIES INC.227
TABLE 231AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW227
FIGURE 35COMPANY SNAPSHOT: AGILENT TECHNOLOGIES, INC. (2020)228
13.10QUANTERIX231
TABLE 232QUANTERIX.: BUSINESS OVERVIEW231
FIGURE 36COMPANY SNAPSHOT: QUANTERIX (2020)232
13.11DIASORIN S.P.A.234
TABLE 233DIASORIN S.P.A.: BUSINESS OVERVIEW234
FIGURE 37COMPANY SNAPSHOT: DIASORIN S.P.A. (2020)235
13.12BIO-TECHNE CORPORATION237
TABLE 234BIO-TECHNE CORPORATION: BUSINESS OVERVIEW237
FIGURE 38COMPANY SNAPSHOT: BIO-TECHNE CORPORATION (2020)238
13.13MESO SCALE DIAGNOSTICS, LLC241
TABLE 235MESO SCALE DIAGNOSTICS, LLC: BUSINESS OVERVIEW241
13.14RANDOX LABORATORIES LTD.243
TABLE 236RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW243
13.15OLINK245
TABLE 237OLINK: BUSINESS OVERVIEW245
13.16OTHER PLAYERS247
13.16.1SEEGENE INC.247
TABLE 238SEEGENE INC.: COMPANY OVERVIEW247
13.16.2PROMEGA CORPORATION248
TABLE 239PROMEGA CORPORATION: COMPANY OVERVIEW248
13.16.3SIEMENS HEALTHINEERS249
TABLE 240SIEMENS HEALTHINEERS: COMPANY OVERVIEW249
13.16.4PERKINELMER INC.250
TABLE 241PERKINELMER INC.: COMPANY OVERVIEW250
13.16.5SHIMADZU CORPORATION251
TABLE 242SHIMADZU CORPORATION: COMPANY OVERVIEW251
13.16.6ANTIGENIX AMERICA, INC.251
TABLE 243ANTIGENIX AMERICA, INC.: COMPANY OVERVIEW251
13.16.7ENZO LIFE SCIENCES, INC.252
TABLE 244ENZO LIFE SCIENCES, INC: COMPANY OVERVIEW252
13.16.8CAYMAN CHEMICAL LTD.253
TABLE 245CAYMAN CHEMICAL LTD.: COMPANY OVERVIEW253
13.16.9BOSTER BIOLOGICAL TECHNOLOGY254
TABLE 246BOSTER BIOLOGICAL TECHNOLOGY: COMPANY OVERVIEW254
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14APPENDIX255
14.1INSIGHTS OF INDUSTRY EXPERTS255
14.2DISCUSSION GUIDE256
14.3KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL261
14.4AVAILABLE CUSTOMIZATIONS263
14.5RELATED REPORTS264
14.6AUTHOR DETAILS266


    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com